Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance

Diabetes

Volumn 48, Issue 11, 1999, Pages 2197-2203

  Weyer, Christian ^a   Bogardus, Clifton ^a   Pratley, Richard E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESPONSE; MALE; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; ARIZONA; BLOOD GLUCOSE; BODY CONSTITUTION; BODY WEIGHT; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INDIANS, NORTH AMERICAN; INFUSIONS, INTRAVENOUS; INSULIN; MALE; REGRESSION ANALYSIS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0032710789     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.11.2197     Document Type: Article

References (50)

1. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
2. Bogardus C: Metabolic abnormalities in the development of non-insulin dependent diabetes mellitus. In Diabetes Mellitus. LeRoith D, Taylor SI, Olewski JM, Eds. Philadelphia, Lippincot-Raven, 1996, p. 459-467
3. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Reaven GM, Hollenbeck CB, Chen YDI: Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55, 1989
5. Golay A, Chen YDI, Reaven GM: Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free-fatty acid metabolism in obese individuals. J Clin Endocrinol Metab 62:1081-1088, 1986
6. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
7. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337-433, 1989
8. Pimenta W, Mitrakou A, Jensen T, Yki-Jarvinen H, Daily G, Gerich J: Insulin secretion and insulin deficiency in people with impaired glucose tolerance. Diabet Med 13:S33-S36, 1996
9. Yoneda H, Ikemagi H, Yamamoto E, Yamato E, Cha T, Kawaguchi Y, Tahara Y, Ogihara T: Analysis of early-phase insulin responses in non-obese subjects with mild glucose intolerance. Diabetes Care 15:1517-1521, 1992
10. Kosaka K, Kuzuya T, Hagura R, Yoshinada H: Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 13: S109-S119, 1996
11. Zimmet P, Whitehouse S, Alford F, Chisholm D: The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15:23-27, 1978
12. Perriello G, Pampanelli S, Del Sindaco P, Ialli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB: Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 46:1010-1016, 1997
13. DeFronzo RA: Lilly Lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
14. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diab Rev 3:177-269, 1997
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (Committee Report). Diabetes Care 21 (Suppl. 1):S5-S19, 1998
16. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet i:1373-1376, 1980
17. Charles MA, Balkau B, Vauzelle-Kervoeden F, Thibult N, Eschwege E: Revision of diagnostic criteria for diabetes (Letter). Lancet 348:1657-1658, 1996
18. Klein R, Barrett-Connor EL, Blunt BA, Wingard DL: Visual impairment and retinopathy in people with normal glucose tolerance, impaired glucose tolerance and newly diagnosed NIDDM. Diabetes Care 14:914-918, 1991
19. McCartney P, Keen H, Jarrett RJ: The Bedford Survey: observations on retina and lens of subjects with impaired glucose tolerance and in controls with normal glucose tolerance. Diabet Med 9:303-305, 1993
20. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D Jr: Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222-229, 1976
21. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence risk factors and pathogenesis. Diabetes Metab Rev 6:1-27, 1990
22. O'Rahilly SO, Hattersley A, Vaag A, Gray H: Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy? Lancet 344:585-589, 1994
23. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as pre-cursors of non-insulin dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
24. Goldman RF, Buskirk ER: A method for underwater weighing and the determination of body density. In Techniques for Measuring Body Composition. Brozek J, Herschel A, Eds. Washington D.C., National Academy of Sciences, 1961, p. 78-106
25. Mazess RB, Barden HS, Bisek JP, Hanson J: Dual-energy x-ray absorptiometry for total-body and regional bone-mineral content and soft-tissue composition. Am J Clin Nutr 62:730-734, 1995
26. Siri WE: Body composition from fluid spaces and density: analysis of methods. In Techniques for Measuring Body Composition. Brozek J, Herschel A, Eds. Washington D.C., National Academy of Sciences, 1961, p. 223-244
27. Tataranni PA, Ravussin E: Use of dual-energy x-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730-734, 1995
28. Tataranni PA, Larson DE, Ravussin E: Body fat distribution and energy metabolism in obese men and women. J Am Coll Nutr 13:569-574, 1994
29. Bogardus C, Lillioja S, Mott D, Reavon JR, Kashiwagi A, Foley JE: Relationship between obesity and maximal stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 78:1568-1578, 1984
30. Bogardus C, Lillioja S, Ravussin E: Familial dependence of the resting metabolic rate. N Engl J Med 315:96-100, 1986
31. Lillioja S, Bogardus C: Obesity and insulin resistance: lessons learned from the Pima Indians. Diab Metab Rev 4:517-540, 1988
32. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C: Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 80:1571-1576, 1995
33. Herbert Y, Lau K, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocr Metab 25:1375-1384, 1965
34. Yalow RS, Berson SA: Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157-1167, 1960
35. SAS Institute: SAS/STAT User's Guide. Version 6.4th Ed. Cary, NC, SAS, 1990
36. Larsson G, Berglung G, Lindgarde F, Ahren B: Comparison of ADA and WHO criteria for the diagnosis of diabetes and glucose tolerance (Letter). Diabetologia 41:1124-1125, 1998
37. Kelley DE, Mokaw M, Mandarino LJ: Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698-706, 1992
38. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman G: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13 C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
39. Leahy JL: Natural history of β-cell dysfunction in NIDDM. Diabetes Care 13:982-1010, 1990
40. Porte D Jr: Banting Lecture 1990: β-cells in type 2 diabetes mellitus. Diabetes 40:166-180, 1990
41. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
42. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
43. Osei K: Increased basal glucose production and utilization in non-diabetic first-degree relatives of patients with NIDDM. Diabetes 39:597-601, 1990
44. Proietto J, Nankerios A, Traikenedes K, Rosella J, O'dea K: Identification of early metabolic defects in young people from a diabetes-prone Australian Aboriginal community (Abstract). Diab Res Clin Proc 5 (Suppl. 1):263, 1988
45. Osei K, Cottrell DA, Harris B: Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 diabetes. J Clin Endocrinol Metab 75:82-86, 1992
46. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
47. Diabetes Prevention Program Research Group: The Diabetes Prevention Program (DPP) (Abstract). Diabetes 46 (Suppl. 1):138A, 1997
48. Azen SP, Peters RK, Berkowitz K, Kjos S, Xiang A, Buchanan TA: TRIPOD (troglitazone in the prevention of diabetes): a randomized, placebo-controlled trial of troglitazone in women with previous gestational diabetes mellitus. Control Clin Trials 19:217-231, 1998
49. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M: The STOP-NIDDM Trial: an international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Diabetes Care 21:1720-1725, 1998
50. Weyer C, Hanson K, Bogardus C, Pratley RE: Long-term changes in insulin action and insulin secretion associated with loss, gain, maintenance, and regain of body weight. Diabetologia. In press